Skip to main content

The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study

Buy Article:

$51.00 plus tax (Refund Policy)


Abstract Background:

The cost of diabetes is high for both the individual and society. Future health-care planning requires patient-level diabetes-attributable health-care cost data that have not previously been available for Australia. Aim:

To determine Australian national direct diabetes-attributable health-care costs for known type 2 diabetes in 2000 and project these to 2051. Methods:

A total of 1294 patients with type 2 diabetes was recruited to the Fremantle Diabetes Study between 1993 and 1996. A bottom-up, prevalence-based approach using diabetes-attributable costs provided average annual per patient health-care costs (in year 2000 A$). Costs were extrapolated to 2051 using Australian type 2 diabetes prevalence figures and Australian Bureau of Statistics population projections, assuming that prevalence rates (i) remain at current levels and (ii) rise steadily. Results:

Total annual direct diabetes-attributable health-care costs in 2000 in Australia for people ≥25 years with known type 2 diabetes were estimated at A$636 million. As a result of ageing, the number of people with type 2 diabetes will double between 2000 and 2051 with a 2.5-fold increase in diabetes-attributable health-care costs. If obesity and inactivity prevalence rates continue to rise, prevalence rates of type 2 diabetes will further increase. The number of people with type 2 diabetes in 2051 may be 3.5 times higher than in 2000 with a 3.7-fold cost increase. Conclusions:

The financial burden of treating type 2 diabetes could quadruple by 2051 unless more is done to prevent type 2 diabetes and its complications. A smaller proportion of the population will have the capacity to fund these rising health-care costs.

Keywords: cross-sectional studies; diabetes mellitus type 2; forecasting; health-care costs; prevalence

Document Type: Research Article


Affiliations: 1: School of Population Health, Perth, Western Australia, Australia 2: University of Western Australia, School of Medicine and Pharmacology

Publication date: March 1, 2006

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more